NeoGenomics Inc (NEO)

Net profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -87,968 -96,329 -114,665 -125,637 -144,250 -163,322 -146,818 -35,642 -8,348 48,828 71,733 -10,964 4,172 -4,949 -5,363 3,452 8,006 2,063 1,943 -428
Revenue (ttm) US$ in thousands 601,638 580,487 554,336 529,041 507,523 493,983 486,680 484,258 482,622 482,400 486,504 451,757 442,254 425,319 404,547 419,283 408,830 378,437 342,861 308,894
Net profit margin -14.62% -16.59% -20.69% -23.75% -28.42% -33.06% -30.17% -7.36% -1.73% 10.12% 14.74% -2.43% 0.94% -1.16% -1.33% 0.82% 1.96% 0.55% 0.57% -0.14%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-87,968K ÷ $601,638K
= -14.62%

Neogenomics Inc.'s net profit margin has shown a downward trend over the past eight quarters, declining from -7.33% in Q1 2022 to -23.71% in Q1 2023. The company experienced significant fluctuations in profitability, with the lowest net profit margin recorded in Q3 2022 at -32.88%. This indicates that the company's ability to generate profit from its revenue has been deteriorating over time. It is important for Neogenomics Inc. to closely monitor and address the factors contributing to this decline in profitability to ensure sustainable financial performance in the future.